Daratumumab Plus CyBorD for Patients With Newly Diagnosed AL Amyloidosis: Safety Run-in Results of ANDROMEDA.
暂无分享，去创建一个
M. Maurer | J. Kaufman | E. Kastritis | G. Merlini | T. Kovacsovics | E. Medvedova | J. Zonder | J. Vermeulen | B. Weiss | M. Minnema | G. Palladini | A. Wechalekar | V. Sanchorawala | A. Jaccard | R. Comenzo | X. Qin | Hans C. Lee | M. Rosenzweig | S. Vasey | N. Bumma